Grown Rogue International (GRUSF) Change in Receivables (2010 - 2012)
Grown Rogue International's (GRUSF) quarterly Change in Receivables came in at $5269.5 in Q2 2012, up 104.06% year-on-year from $2582.3 in Q2 2011, and up 104.06% quarter-over-quarter from -$129648.2 in Q2 2011.
Grown Rogue International (GRUSF) Change in Receivables (2010 - 2012) Analysis & Trends
Grown Rogue International's Change in Receivables history runs 3 years deep, the most recent figure standing at $5269.5 for Q2 2012.
- On a quarterly basis, Change in Receivables rose 104.06% year-over-year to $5269.5 in Q2 2012; TTM through May 2012 was -$126855.5, a N/A change from a year earlier, with the FY2010 full-year figure at -$8952.0, down 12.93% from the prior year.
- Change in Receivables improved to $5269.5 in Q2 2012 per GRUSF's latest filing, from -$129648.2 in the prior quarter.
- Across five years, Change in Receivables topped out at $5269.5 in Q2 2012 and bottomed at -$129648.2 in Q2 2011.
- The 3-year median for Change in Receivables is -$1238.4 (2010), against an average of -$31713.9.
- Across the five-year window, Change in Receivables plunged 13121.91% in 2011 and surged 104.06% in 2012, its largest moves.
- Year by year, Change in Receivables stood at -$3472.4 in 2010, then plunged by 3633.71% to -$129648.2 in 2011, then jumped by 104.06% to $5269.5 in 2012.
- Per Business Quant, the three latest GRUSF Change in Receivables figures stand at $5269.5 (Q2 2012), -$129648.2 (Q2 2011), and -$3472.4 (Q3 2010).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -78.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 106.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -621.82 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -38.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 126.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 81.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Grown Rogue International | 99.97 Mn | 92.67 Mn | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2012 | 5,269.46 |
| May 31, 2012 | 5,269.46 |
| May 31, 2011 | -129,648.24 |
| May 31, 2011 | -129,648.24 |
| Aug 31, 2010 | -3,472.37 |
| Aug 31, 2010 | -3,472.37 |
| May 31, 2010 | 995.62 |
| May 31, 2010 | 995.62 |